Skip to content

NICD-CRT Stuy

Assessment of cardiac resynchronization therapy in patients with wide QRS-complex and non-specific intraventricular conduction delay: a randomized trial. - NICD-CRT Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54616
Enrollment
30
Registered
2018-04-11
Start date
2020-02-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

A pacemaker or defibrillator associated with a CRT system will be implanted according to the standard care procedures. The decision to implant a pacemaker or a defibrillator associated with CRT system

Sponsors

Clermont-Ferrand University Hospital
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years* old - NYHA class II to IV ambulatory - QRS duration > 130 ms - Patients with sinus rhythm - LVEF

Exclusion criteria

Exclusion criteria: - Inability to understand nor decline the study, - Impaired mobility, - Unable to fill out questionnaire independently, - Patients with permanent atrial fibrillation, - Pregnant women, - Dependant adult, - Patients minor, - Life expectancy

Design outcomes

Primary

MeasureTime frame
Composite of 2 clinical endpoints (12 months all-cause deaths and percentage of hospitalizations for HF at 12 months) combined using an average z-score.

Secondary

MeasureTime frame
Evaluation of efficacy, analysis of: - 12- month deaths (HF, cardiovascular and all causes deaths), - Quality-of-life questionnaires at 6 and 12 months: o Minnesota Living With Heart Failure Questionnaire: MLWHFQ): improvement of at least 20 points - Functional capacity at 6 and 12 months: o NYHA classification reduction >= 1 class, o 6-minute walk test improvement of at least 10 % in distance, o Peak oxygen consumption increased by 1.0 ml/kg/min13, - Percentage of hospitalizations for HF, for cardiovascular reasons and for allcauses at 6 and 12 months, - Decrease >15% in end-diastolic and/or end-systolic volumes of the left ventricle at 6 and 12 months. Packer score assessment

Countries

France, Netherlands

Contacts

Public ContactR Eschalie

Clermont-Ferrand University Hospital

reschalier@chu-clermontferrand.fr+33 (0)4.73.75.24.89

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)